An Analytical Method to Monitor Dietary Fat Intake
By LabMedica International staff writers Posted on 25 May 2020 |

Image: A multisegment injection-non-aqueous-capillary electrophoresis–mass spectrometer (MSI-NACE-MS) (Photo courtesy of McMaster University)
An advanced analytical technique was used to determine unequivocally the composition of fats in the diets of pregnant women and female patients suspected of being deficient in certain dietary fats.
Investigators at McMaster University (Hamilton, Ontario, Canada) sought to develop a method to monitor objectively dietary fat intake in women that would be complementary to the currently used self-kept dietary records or food frequency questionnaires. For this purpose, they turned to the advanced analytical technique known as multisegment injection-non-aqueous-capillary electrophoresis–mass spectrometry or MSI-NACE-MS.
Capillary electrophoresis-mass spectrometry (CE-MS), is a high efficiency microseparation platform that is ideal for analysis of a broad range of ionic metabolites in volume-restricted or mass-limited biological specimens. Selectivity in CE is based on differences in the electrophoretic mobility of metabolites in aqueous or non-aqueous buffer conditions that can be predicted accurately based on their physicochemical properties, which is coupled to an electrospray ionization (ESI) source prior to high resolution, accurate mass analysis.
The method includes sequential injection of multiple sample segments in series within a single capillary, the sample segments being separated by a spacer plug of buffer, and multiplexed analysis of the sample segments simultaneously within a single capillary electrophoresis run. Classes of metabolites optimal to CE-MS include amino acids, biogenic amines, organic acids, nucleotides, sugar phosphates, acylcarnitines, acylglycines, fatty acids, and various drugs/exogenous compounds that often require minimal sample pretreatment while using small volumes (five to 20 microliters) of biological samples (e.g., urine, plasma, sweat, tissue biopsies), including dried blood spots cut-out on filter paper.
For the current study, the investigators used MSI-NACE-MS to investigate whether specific serum non-esterified fatty acids (NEFA) would have utility as biomarkers of dietary fat intake in women. Initially, they identified circulating NEFAs that correlated with long-term/habitual food intake among 50 pregnant women with contrasting dietary patterns. Acute changes in serum NEFA trajectories were also studied in 18 non-pregnant women following high-dose (five grams/day) fish oil supplementation or sunflower oil placebo over 56 days.
Results from the cohort of pregnant women revealed that serum omega-3 fatty acid correlated with self-reported total omega-3 daily intake, notably eicosapentaenoic acid (EPA) as its NEFA, whereas pentadecanoic acid was associated with full-fat dairy intake. These outcomes were consistent with results from total fatty acid serum hydrolysates.
In the intervention cohort, serum omega-3 NEFAs increased 2.5-fold from baseline within 28 days following fish oil supplementation, and this increase was most pronounced for EPA. Unlike for docosahexaenoic acid, circulating EPA, as its NEFA, also strongly correlated to EPA concentrations measured from erythrocyte phospholipid hydrolysates and was better suited to detect dietary non-adherence.
"The food we consume is highly complex and difficult to measure when relying on self-reporting or memory recall, particularly in the case of dietary fats. There are thousands of chemicals that we are exposed to in foods, both processed and natural. Epidemiologists need better ways to reliably assess dietary intake when developing nutritional recommendations," said senior author Dr. Philip Britz-McKibbin, professor of chemistry and chemical biology at McMaster University. "Fat intake is among the most controversial aspects of nutritional public health policies given previously flawed low-fat diet recommendations, and the growing popularity of low-carb/high-fat ketogenic based diets. If we can measure it reliably, we can begin to study such questions as: Should pregnant women take fish oil? Are women deficient in certain dietary fats? Does a certain diet or supplement lead to better health outcomes for their babies?"
The dietary fat study was published in the March 31, 2020, online edition of the Journal of Lipid Research.
Related Links:
McMaster University
Investigators at McMaster University (Hamilton, Ontario, Canada) sought to develop a method to monitor objectively dietary fat intake in women that would be complementary to the currently used self-kept dietary records or food frequency questionnaires. For this purpose, they turned to the advanced analytical technique known as multisegment injection-non-aqueous-capillary electrophoresis–mass spectrometry or MSI-NACE-MS.
Capillary electrophoresis-mass spectrometry (CE-MS), is a high efficiency microseparation platform that is ideal for analysis of a broad range of ionic metabolites in volume-restricted or mass-limited biological specimens. Selectivity in CE is based on differences in the electrophoretic mobility of metabolites in aqueous or non-aqueous buffer conditions that can be predicted accurately based on their physicochemical properties, which is coupled to an electrospray ionization (ESI) source prior to high resolution, accurate mass analysis.
The method includes sequential injection of multiple sample segments in series within a single capillary, the sample segments being separated by a spacer plug of buffer, and multiplexed analysis of the sample segments simultaneously within a single capillary electrophoresis run. Classes of metabolites optimal to CE-MS include amino acids, biogenic amines, organic acids, nucleotides, sugar phosphates, acylcarnitines, acylglycines, fatty acids, and various drugs/exogenous compounds that often require minimal sample pretreatment while using small volumes (five to 20 microliters) of biological samples (e.g., urine, plasma, sweat, tissue biopsies), including dried blood spots cut-out on filter paper.
For the current study, the investigators used MSI-NACE-MS to investigate whether specific serum non-esterified fatty acids (NEFA) would have utility as biomarkers of dietary fat intake in women. Initially, they identified circulating NEFAs that correlated with long-term/habitual food intake among 50 pregnant women with contrasting dietary patterns. Acute changes in serum NEFA trajectories were also studied in 18 non-pregnant women following high-dose (five grams/day) fish oil supplementation or sunflower oil placebo over 56 days.
Results from the cohort of pregnant women revealed that serum omega-3 fatty acid correlated with self-reported total omega-3 daily intake, notably eicosapentaenoic acid (EPA) as its NEFA, whereas pentadecanoic acid was associated with full-fat dairy intake. These outcomes were consistent with results from total fatty acid serum hydrolysates.
In the intervention cohort, serum omega-3 NEFAs increased 2.5-fold from baseline within 28 days following fish oil supplementation, and this increase was most pronounced for EPA. Unlike for docosahexaenoic acid, circulating EPA, as its NEFA, also strongly correlated to EPA concentrations measured from erythrocyte phospholipid hydrolysates and was better suited to detect dietary non-adherence.
"The food we consume is highly complex and difficult to measure when relying on self-reporting or memory recall, particularly in the case of dietary fats. There are thousands of chemicals that we are exposed to in foods, both processed and natural. Epidemiologists need better ways to reliably assess dietary intake when developing nutritional recommendations," said senior author Dr. Philip Britz-McKibbin, professor of chemistry and chemical biology at McMaster University. "Fat intake is among the most controversial aspects of nutritional public health policies given previously flawed low-fat diet recommendations, and the growing popularity of low-carb/high-fat ketogenic based diets. If we can measure it reliably, we can begin to study such questions as: Should pregnant women take fish oil? Are women deficient in certain dietary fats? Does a certain diet or supplement lead to better health outcomes for their babies?"
The dietary fat study was published in the March 31, 2020, online edition of the Journal of Lipid Research.
Related Links:
McMaster University
Latest Technology News
- Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer
- Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
- Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
- Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
- Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
- Smartphones Could Diagnose Diseases Using Infrared Scans
- Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
- 3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
- POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
- Study Explores Impact of POC Testing on Future of Diagnostics
- Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
- Nanotechnology For Cervical Cancer Diagnosis Could Replace Invasive Pap Smears
- Lab-On-Chip Platform to Expedite Cancer Diagnoses
- Biosensing Platform Simultaneously Detects Vitamin C and SARS-CoV-2
- New Lens Method Analyzes Tears for Early Disease Detection
- FET-Based Sensors Pave Way for Portable Diagnostic Devices Capable of Detecting Multiple Diseases
Channels
Clinical Chemistry
view channel
AI-Powered Blood Test Accurately Detects Ovarian Cancer
Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more
Automated Decentralized cfDNA NGS Assay Identifies Alterations in Advanced Solid Tumors
Current circulating cell-free DNA (cfDNA) assays are typically centralized, requiring specialized handling and transportation of samples. Introducing a flexible, decentralized sequencing system at the... Read moreMass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication
Speed and accuracy are essential when diagnosing diseases. Traditionally, diagnosing bacterial infections involves the labor-intensive process of isolating pathogens and cultivating bacterial cultures,... Read more
First Comprehensive Syphilis Test to Definitively Diagnose Active Infection In 10 Minutes
In the United States, syphilis cases have surged by nearly 80% from 2018 to 2023, with 209,253 cases recorded in the most recent year of data. Syphilis, which can be transmitted sexually or from mother... Read moreHematology
view channel
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read more
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Molecular Stool Test Shows Potential for Diagnosing TB in Adults with HIV
Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, led to 1.25 million deaths in 2023, with 13% of those occurring in people living with HIV. The current primary diagnostic method for... Read more
New Test Diagnoses Bacterial Meningitis Quickly and Accurately
Bacterial meningitis is a potentially fatal condition, with one in six patients dying and half of the survivors experiencing lasting symptoms. Therefore, rapid diagnosis and treatment are critical.... Read morePathology
view channel
Groundbreaking Chest Pain Triage Algorithm to Transform Cardiac Care
Cardiovascular disease is responsible for a third of all deaths worldwide, and chest pain is the second most common reason for emergency department (ED) visits. With EDs often being some of the busiest... Read more
AI-Based Liquid Biopsy Approach to Revolutionize Brain Cancer Detection
Detecting brain cancers remains extremely challenging, with many patients only receiving a diagnosis at later stages after symptoms like headaches, seizures, or cognitive issues appear. Late-stage diagnoses... Read moreTechnology
view channel
Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer
Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more